Hallett DC - Search Results

1

Natural history of hypercholesterolemia in systemic lupus erythematosus.

Bruce IN, Urowitz MB, Gladman DD, Hallett DC. Bruce IN, et al. Among authors: hallett dc. J Rheumatol. 1999 Oct;26(10):2137-43. J Rheumatol. 1999. PMID: 10529129

2

Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.

Kim TH, Stone MA, Rahman P, Yoo DH, Park YW, Payne U, Hallett D, Inman RD. Kim TH, et al. J Rheumatol. 2005 Oct;32(10):1907-10. J Rheumatol. 2005. PMID: 16206345

3

Analysis of CARD15 polymorphisms in Korean patients with ankylosing spondylitis reveals absence of common variants seen in western populations.

Kim TH, Rahman P, Jun JB, Lee HS, Park YW, Im HJ, Snelgrove T, Peddle L, Hallett D, Inman RD. Kim TH, et al. J Rheumatol. 2004 Oct;31(10):1959-61. J Rheumatol. 2004. PMID: 15468360

4

Prospective trial of high-frequency oscillation in adults with acute respiratory distress syndrome.

Mehta S, Lapinsky SE, Hallett DC, Merker D, Groll RJ, Cooper AB, MacDonald RJ, Stewart TE. Mehta S, et al. Among authors: hallett dc. Crit Care Med. 2001 Jul;29(7):1360-9. doi: 10.1097/00003246-200107000-00011. Crit Care Med. 2001. PMID: 11445688 Clinical Trial.

5

Serial renal biopsy in systemic lupus erythematosus.

Bajaj S, Albert L, Gladman DD, Urowitz MB, Hallett DC, Ritchie S. Bajaj S, et al. Among authors: hallett dc. J Rheumatol. 2000 Dec;27(12):2822-6. J Rheumatol. 2000. PMID: 11128670

6

Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus.

Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz MB. Tam LS, et al. Among authors: hallett dc. J Rheumatol. 2000 Sep;27(9):2142-5. J Rheumatol. 2000. PMID: 10990225

7

Factors associated with fatigue in patients with systemic lupus erythematosus.

Bruce IN, Mak VC, Hallett DC, Gladman DD, Urowitz MB. Bruce IN, et al. Among authors: hallett dc. Ann Rheum Dis. 1999 Jun;58(6):379-81. doi: 10.1136/ard.58.6.379. Ann Rheum Dis. 1999. PMID: 10340963 Free PMC article.

8

Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.

Bruce IN, Hallett DC, Gladman DD, Urowitz MB. Bruce IN, et al. Among authors: hallett dc. J Rheumatol. 1999 Jul;26(7):1490-4. J Rheumatol. 1999. PMID: 10405935

9

Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus.

Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Rahman P, et al. Lupus. 2001;10(2):93-6. doi: 10.1191/096120301670679959. Lupus. 2001. PMID: 11237132

10

Vascular events in hypertensive patients with systemic lupus erythematosus.

Rahman P, Aguero S, Gladman DD, Hallett D, Urowitz MB. Rahman P, et al. Lupus. 2000;9(9):672-5. doi: 10.1191/096120300669204787. Lupus. 2000. PMID: 11199921

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results